Quickening: Translational design of resorbable synthetic vascular grafts
- PMID: 29772461
- PMCID: PMC6492619
- DOI: 10.1016/j.biomaterials.2018.05.006
Quickening: Translational design of resorbable synthetic vascular grafts
Abstract
Traditional tissue-engineered vascular grafts have yet to gain wide clinical use. The difficulty of scaling production of these cell- or biologic-based products has hindered commercialization. In situ tissue engineering bypasses such logistical challenges by using acellular resorbable scaffolds. Upon implant, the scaffolds become remodeled by host cells. This review describes the scientific and translational advantages of acellular, synthetic vascular grafts. It surveys in vivo results obtained with acellular synthetics over their fifty years of technological development. Finally, it discusses emerging principles, highlights strategic considerations for designers, and identifies questions needing additional research.
Keywords: Biodegradable; Degradable vascular graft; Host remodeling; In situ tissue engineering.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Figures
References
-
- Kim LK, Swaminathan RV, Minutello RM, Gade CL, Yang DC, Charitakis K, et al. Trends in hospital treatments for peripheral arterial disease in the United States and association between payer status and quality of care/outcomes, 2007–2011. Catheter Cardiovasc Interv. 2015;86(5):864–72. - PubMed
-
- USRDS. Chapter 4: Vascular access. In: 2015 Annual Data Report. 2015. p. 197–210.
-
- USRDS. Chapter 1: Incidence, prevalence, patient characteristics, and treatment modalities. In: 2015 Annual Data Report. 2015. p. 139–58.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
